Position in DXCM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$535,567
+$4,593 QoQ
Shares Held
7,952
-5.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#569
of 971 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SAGESPRING WEALTH PARTNERS, LLC holds $6,321,312 across 7 Medical Devices names. DXCM ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
18,978 | $1,722,063 | |
| 2 | EW |
Edwards Lifesciences Corp
|
11,515 | $1,041,646 | |
| 3 | SYK |
Stryker Corp
|
3,122 | $982,930 | |
| 4 | MDT |
Medtronic plc
|
11,922 | $932,658 | |
| 5 | STE |
STERIS plc
|
3,223 | $678,667 | |
| 6 | DXCM |
Dexcom Inc
This page
|
7,952 | $535,567 | |
| 7 | BSX |
Boston Scientific Corp
|
10,023 | $427,781 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $535,567 | 7,952 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $530,974 | 8,455 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $684,141 | 10,308 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $702,305 | 10,437 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $961,673 | 11,017 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $720,596 | 10,552 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $418,402 | 5,380 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||